Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161447 · ClinicalTrials.gov registry record · Phase 1
Male Hormonal Contraceptive Development-ACY-5
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
NCT00161447: Completed Phase 1 study, sponsored by University of Washington.
NCT00161447 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 43 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00161447, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this research study is to help in the development of male contraception (birth control).
Interventions
- DRUG Acyline
- DRUG Testosterone Gel
- DRUG Depo-Medroxyprogesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2004-05 |
| Est. Completion | 2006-04 |
| Phase | Phase 1 |
What the finished NCT00161447 record still lists
NCT00161447 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 3 interventions - of which Acyline is the first listed.
NCT00161447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00161447 about?
NCT00161447 is a clinical study titled "Male Hormonal Contraceptive Development-ACY-5". The purpose of this research study is to help in the development of male contraception (birth control).
What is the current status of trial NCT00161447?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2004-05. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00161447?
The interventions under investigation include: Acyline (DRUG), Testosterone Gel (DRUG), Depo-Medroxyprogesterone (DRUG).
Who is sponsoring clinical trial NCT00161447?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00161447's enrollment target sits among peer trials
43 1100th of 2000 higher than 896 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia